| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Netherlands | 206 | 2024 | 2222 | 7.270 |
Why?
|
| Cardiovascular Diseases | 159 | 2024 | 15513 | 5.860 |
Why?
|
| Life Expectancy | 35 | 2024 | 1242 | 5.110 |
Why?
|
| Menopause | 19 | 2023 | 1646 | 3.550 |
Why?
|
| Diet | 74 | 2024 | 8047 | 3.250 |
Why?
|
| Carotid Artery Diseases | 29 | 2023 | 877 | 3.250 |
Why?
|
| Diabetes Mellitus, Type 2 | 67 | 2024 | 12145 | 2.730 |
Why?
|
| Feeding Behavior | 31 | 2021 | 3183 | 2.600 |
Why?
|
| Blood Pressure | 60 | 2024 | 8478 | 2.320 |
Why?
|
| Body Mass Index | 101 | 2021 | 12951 | 2.310 |
Why?
|
| Dietary Proteins | 22 | 2019 | 951 | 2.220 |
Why?
|
| Prospective Studies | 242 | 2024 | 54419 | 2.140 |
Why?
|
| Body Composition | 22 | 2021 | 2427 | 2.120 |
Why?
|
| Coronary Disease | 31 | 2022 | 5921 | 2.090 |
Why?
|
| Risk Factors | 269 | 2024 | 74219 | 2.060 |
Why?
|
| Exercise | 34 | 2023 | 5872 | 2.040 |
Why?
|
| DNA Methylation | 28 | 2020 | 4386 | 1.990 |
Why?
|
| Life Style | 36 | 2024 | 3908 | 1.900 |
Why?
|
| Cardiovascular System | 7 | 2023 | 836 | 1.890 |
Why?
|
| Plaque, Atherosclerotic | 19 | 2023 | 1535 | 1.860 |
Why?
|
| Aged | 367 | 2024 | 169266 | 1.850 |
Why?
|
| Female | 558 | 2024 | 392458 | 1.810 |
Why?
|
| Thyrotropin | 16 | 2020 | 834 | 1.790 |
Why?
|
| Humans | 728 | 2024 | 761098 | 1.780 |
Why?
|
| Genome-Wide Association Study | 101 | 2024 | 12670 | 1.750 |
Why?
|
| Hypertension | 44 | 2024 | 8537 | 1.700 |
Why?
|
| Middle Aged | 381 | 2024 | 220835 | 1.690 |
Why?
|
| Infant Nutritional Physiological Phenomena | 11 | 2017 | 351 | 1.680 |
Why?
|
| Lutein | 4 | 2017 | 123 | 1.640 |
Why?
|
| Aging | 41 | 2024 | 8701 | 1.630 |
Why?
|
| Cohort Studies | 156 | 2024 | 41486 | 1.620 |
Why?
|
| Thyroxine | 13 | 2020 | 666 | 1.620 |
Why?
|
| Male | 493 | 2024 | 360675 | 1.610 |
Why?
|
| Vitamin D | 24 | 2024 | 3302 | 1.610 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 12 | 2019 | 390 | 1.600 |
Why?
|
| Genetic Loci | 30 | 2020 | 2623 | 1.570 |
Why?
|
| Postmenopause | 14 | 2020 | 2511 | 1.530 |
Why?
|
| Thyroid Gland | 12 | 2020 | 1170 | 1.480 |
Why?
|
| Energy Intake | 24 | 2021 | 2133 | 1.420 |
Why?
|
| Obesity | 40 | 2020 | 12937 | 1.380 |
Why?
|
| Polymorphism, Single Nucleotide | 78 | 2024 | 15915 | 1.360 |
Why?
|
| Natriuretic Peptide, Brain | 9 | 2020 | 1725 | 1.360 |
Why?
|
| Infant Food | 7 | 2017 | 139 | 1.340 |
Why?
|
| Sex Hormone-Binding Globulin | 6 | 2018 | 550 | 1.330 |
Why?
|
| Chagas Cardiomyopathy | 3 | 2020 | 71 | 1.330 |
Why?
|
| Hot Flashes | 4 | 2016 | 330 | 1.330 |
Why?
|
| Vitamin D Deficiency | 16 | 2024 | 1388 | 1.300 |
Why?
|
| Phytoestrogens | 6 | 2020 | 59 | 1.280 |
Why?
|
| Thyroid Function Tests | 11 | 2019 | 288 | 1.270 |
Why?
|
| Fatty Acids, Unsaturated | 5 | 2016 | 540 | 1.250 |
Why?
|
| Fishes | 10 | 2018 | 601 | 1.240 |
Why?
|
| Carotid Arteries | 16 | 2019 | 941 | 1.210 |
Why?
|
| Databases, Bibliographic | 2 | 2018 | 130 | 1.190 |
Why?
|
| Stroke | 45 | 2022 | 9720 | 1.170 |
Why?
|
| Chronic Disease | 18 | 2024 | 9317 | 1.160 |
Why?
|
| Antioxidants | 7 | 2019 | 1667 | 1.160 |
Why?
|
| Sweating | 4 | 2016 | 155 | 1.150 |
Why?
|
| Epigenesis, Genetic | 21 | 2020 | 3790 | 1.140 |
Why?
|
| Child Development | 17 | 2019 | 2302 | 1.130 |
Why?
|
| Dyslipidemias | 8 | 2024 | 870 | 1.120 |
Why?
|
| Population Surveillance | 30 | 2018 | 2599 | 1.120 |
Why?
|
| C-Reactive Protein | 21 | 2018 | 3821 | 1.120 |
Why?
|
| Coronary Artery Disease | 31 | 2024 | 6504 | 1.110 |
Why?
|
| Dietary Supplements | 16 | 2023 | 3410 | 1.110 |
Why?
|
| Health Status | 18 | 2023 | 4077 | 1.110 |
Why?
|
| Socioeconomic Factors | 29 | 2021 | 7804 | 1.090 |
Why?
|
| Prediabetic State | 11 | 2022 | 545 | 1.080 |
Why?
|
| Insulin Resistance | 21 | 2024 | 3951 | 1.080 |
Why?
|
| Menopause, Premature | 5 | 2022 | 124 | 1.080 |
Why?
|
| Longevity | 13 | 2024 | 1064 | 1.070 |
Why?
|
| Insulin | 32 | 2024 | 6588 | 1.070 |
Why?
|
| Proportional Hazards Models | 59 | 2022 | 12467 | 1.060 |
Why?
|
| Food Preferences | 6 | 2017 | 398 | 1.060 |
Why?
|
| Cause of Death | 18 | 2020 | 3688 | 1.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 13 | 2022 | 3245 | 1.040 |
Why?
|
| Cross-Sectional Studies | 90 | 2024 | 26068 | 1.030 |
Why?
|
| Metabolic Diseases | 10 | 2020 | 680 | 1.030 |
Why?
|
| Atrial Fibrillation | 22 | 2021 | 5115 | 1.020 |
Why?
|
| Health | 4 | 2016 | 398 | 1.000 |
Why?
|
| Dairy Products | 10 | 2021 | 490 | 0.990 |
Why?
|
| Prevalence | 51 | 2024 | 15717 | 0.980 |
Why?
|
| Estrogen Receptor beta | 2 | 2016 | 168 | 0.980 |
Why?
|
| Genetic Predisposition to Disease | 58 | 2024 | 17889 | 0.980 |
Why?
|
| Coronavirus Infections | 7 | 2020 | 3094 | 0.970 |
Why?
|
| Pneumonia, Viral | 7 | 2020 | 3216 | 0.960 |
Why?
|
| Lipids | 20 | 2022 | 3330 | 0.960 |
Why?
|
| Blood Glucose | 28 | 2024 | 6390 | 0.960 |
Why?
|
| Child Behavior | 8 | 2019 | 848 | 0.960 |
Why?
|
| Quantitative Trait Loci | 23 | 2019 | 2113 | 0.950 |
Why?
|
| Waist Circumference | 14 | 2019 | 933 | 0.950 |
Why?
|
| Dietary Fats | 12 | 2019 | 1995 | 0.930 |
Why?
|
| Cholesterol | 18 | 2022 | 2902 | 0.930 |
Why?
|
| Adiposity | 22 | 2019 | 1879 | 0.920 |
Why?
|
| Dietary Fats, Unsaturated | 2 | 2016 | 224 | 0.920 |
Why?
|
| Estradiol | 6 | 2019 | 1936 | 0.910 |
Why?
|
| Overweight | 11 | 2020 | 2418 | 0.910 |
Why?
|
| Lepidoptera | 1 | 2024 | 24 | 0.910 |
Why?
|
| Histones | 4 | 2019 | 2570 | 0.900 |
Why?
|
| Incidence | 69 | 2024 | 21357 | 0.890 |
Why?
|
| Cholesterol, HDL | 25 | 2019 | 1812 | 0.880 |
Why?
|
| Opium | 1 | 2023 | 27 | 0.870 |
Why?
|
| Nutrition Assessment | 18 | 2019 | 726 | 0.860 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2019 | 634 | 0.860 |
Why?
|
| Cholesterol, LDL | 20 | 2024 | 2380 | 0.860 |
Why?
|
| Mendelian Randomization Analysis | 19 | 2022 | 1010 | 0.840 |
Why?
|
| Weight Gain | 9 | 2020 | 2349 | 0.840 |
Why?
|
| Bone Density | 20 | 2019 | 3548 | 0.840 |
Why?
|
| Follow-Up Studies | 77 | 2024 | 39121 | 0.840 |
Why?
|
| Risk Assessment | 56 | 2024 | 24013 | 0.840 |
Why?
|
| Aged, 80 and over | 111 | 2024 | 58946 | 0.830 |
Why?
|
| Information Storage and Retrieval | 2 | 2018 | 818 | 0.820 |
Why?
|
| Seafood | 7 | 2019 | 393 | 0.810 |
Why?
|
| Nutrition Policy | 10 | 2024 | 466 | 0.790 |
Why?
|
| Mortality | 14 | 2022 | 2896 | 0.780 |
Why?
|
| Seasons | 7 | 2019 | 1517 | 0.780 |
Why?
|
| Fatty Acids, Omega-3 | 6 | 2016 | 1390 | 0.780 |
Why?
|
| Meta-Analysis as Topic | 10 | 2019 | 1381 | 0.770 |
Why?
|
| Triglycerides | 23 | 2021 | 2457 | 0.760 |
Why?
|
| Cost of Illness | 4 | 2015 | 1937 | 0.760 |
Why?
|
| Geriatric Assessment | 9 | 2018 | 1409 | 0.750 |
Why?
|
| Glomerular Filtration Rate | 19 | 2019 | 2181 | 0.750 |
Why?
|
| Hypercholesterolemia | 6 | 2024 | 1141 | 0.750 |
Why?
|
| Linear Models | 31 | 2020 | 5869 | 0.750 |
Why?
|
| Chagas Disease | 2 | 2022 | 167 | 0.740 |
Why?
|
| Dementia | 16 | 2023 | 2682 | 0.740 |
Why?
|
| Genetic Variation | 28 | 2019 | 6565 | 0.740 |
Why?
|
| Motor Activity | 12 | 2017 | 2712 | 0.740 |
Why?
|
| Smoking | 28 | 2020 | 9055 | 0.730 |
Why?
|
| MEDLINE | 4 | 2018 | 119 | 0.720 |
Why?
|
| Decision Support Systems, Clinical | 4 | 2015 | 1171 | 0.710 |
Why?
|
| Adult | 150 | 2024 | 221083 | 0.710 |
Why?
|
| Alcohol Drinking | 18 | 2020 | 4028 | 0.700 |
Why?
|
| Sleep | 12 | 2023 | 4761 | 0.690 |
Why?
|
| von Willebrand Factor | 8 | 2019 | 677 | 0.690 |
Why?
|
| Thyroid Diseases | 3 | 2019 | 386 | 0.680 |
Why?
|
| Androgens | 5 | 2024 | 1283 | 0.680 |
Why?
|
| Frail Elderly | 5 | 2018 | 765 | 0.680 |
Why?
|
| Pandemics | 10 | 2024 | 8663 | 0.680 |
Why?
|
| Peptide Fragments | 10 | 2020 | 5103 | 0.670 |
Why?
|
| Age Factors | 39 | 2020 | 18385 | 0.660 |
Why?
|
| Health Behavior | 12 | 2021 | 2641 | 0.660 |
Why?
|
| Nutritive Value | 4 | 2024 | 347 | 0.660 |
Why?
|
| Transients and Migrants | 1 | 2022 | 165 | 0.660 |
Why?
|
| Eating | 10 | 2023 | 1535 | 0.660 |
Why?
|
| Haemophilus Infections | 1 | 2019 | 94 | 0.660 |
Why?
|
| Subject Headings | 1 | 2018 | 17 | 0.650 |
Why?
|
| Cystatin C | 9 | 2022 | 270 | 0.640 |
Why?
|
| Atherosclerosis | 16 | 2022 | 3405 | 0.640 |
Why?
|
| Haemophilus influenzae | 1 | 2019 | 178 | 0.640 |
Why?
|
| Adipokines | 4 | 2017 | 307 | 0.630 |
Why?
|
| Anthropometry | 6 | 2019 | 1338 | 0.630 |
Why?
|
| Genetic Association Studies | 17 | 2019 | 2731 | 0.630 |
Why?
|
| Fibrinogen | 7 | 2019 | 888 | 0.630 |
Why?
|
| Vegetables | 13 | 2022 | 1192 | 0.620 |
Why?
|
| Vasomotor System | 2 | 2016 | 208 | 0.620 |
Why?
|
| Diabetes Mellitus | 15 | 2023 | 5841 | 0.610 |
Why?
|
| Hypothyroidism | 4 | 2018 | 668 | 0.610 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2019 | 130 | 0.610 |
Why?
|
| Cardiovascular Physiological Phenomena | 3 | 2016 | 241 | 0.610 |
Why?
|
| Pregnancy | 42 | 2020 | 29872 | 0.600 |
Why?
|
| Social Isolation | 2 | 2020 | 365 | 0.600 |
Why?
|
| Quarantine | 1 | 2020 | 182 | 0.600 |
Why?
|
| Death, Sudden, Cardiac | 9 | 2018 | 1559 | 0.600 |
Why?
|
| Health Expenditures | 3 | 2015 | 2363 | 0.600 |
Why?
|
| Dehydroepiandrosterone | 3 | 2024 | 258 | 0.590 |
Why?
|
| Masks | 1 | 2020 | 208 | 0.590 |
Why?
|
| Testosterone | 8 | 2024 | 2472 | 0.590 |
Why?
|
| Absorptiometry, Photon | 22 | 2019 | 1738 | 0.590 |
Why?
|
| Kidney | 16 | 2022 | 7034 | 0.590 |
Why?
|
| Child Nutritional Physiological Phenomena | 7 | 2018 | 292 | 0.580 |
Why?
|
| Adipose Tissue | 17 | 2022 | 3309 | 0.570 |
Why?
|
| Folic Acid | 8 | 2023 | 1323 | 0.560 |
Why?
|
| Developing Countries | 4 | 2020 | 2862 | 0.560 |
Why?
|
| Pregnancy Complications | 8 | 2020 | 2948 | 0.550 |
Why?
|
| Prenatal Exposure Delayed Effects | 13 | 2019 | 2518 | 0.550 |
Why?
|
| Acids | 4 | 2019 | 124 | 0.550 |
Why?
|
| Communicable Disease Control | 2 | 2020 | 846 | 0.550 |
Why?
|
| Europe | 24 | 2022 | 3422 | 0.550 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2018 | 190 | 0.550 |
Why?
|
| Quality of Life | 13 | 2024 | 13362 | 0.550 |
Why?
|
| Breast Feeding | 10 | 2017 | 1355 | 0.550 |
Why?
|
| Hemorrhage | 10 | 2020 | 3422 | 0.550 |
Why?
|
| Culture | 1 | 2020 | 623 | 0.550 |
Why?
|
| Cerebrovascular Disorders | 4 | 2015 | 1474 | 0.540 |
Why?
|
| Fertility | 2 | 2023 | 768 | 0.540 |
Why?
|
| Respiratory System | 2 | 2019 | 562 | 0.540 |
Why?
|
| Hyperthyroidism | 2 | 2018 | 294 | 0.540 |
Why?
|
| Primary Prevention | 9 | 2022 | 1185 | 0.540 |
Why?
|
| Renal Insufficiency, Chronic | 10 | 2022 | 2254 | 0.530 |
Why?
|
| Lipid Metabolism | 9 | 2019 | 1893 | 0.530 |
Why?
|
| Electrocardiography | 13 | 2019 | 6385 | 0.530 |
Why?
|
| Progestins | 1 | 2018 | 301 | 0.520 |
Why?
|
| Switzerland | 9 | 2023 | 319 | 0.520 |
Why?
|
| Dietary Carbohydrates | 5 | 2019 | 891 | 0.520 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2020 | 2130 | 0.520 |
Why?
|
| Iran | 3 | 2024 | 736 | 0.520 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2016 | 52 | 0.510 |
Why?
|
| Risk Reduction Behavior | 8 | 2020 | 1111 | 0.510 |
Why?
|
| Meat | 8 | 2019 | 584 | 0.510 |
Why?
|
| Trust | 1 | 2020 | 529 | 0.510 |
Why?
|
| Palmitic Acid | 1 | 2016 | 149 | 0.510 |
Why?
|
| Plant Preparations | 1 | 2016 | 94 | 0.510 |
Why?
|
| Fatty Acids | 5 | 2017 | 1806 | 0.500 |
Why?
|
| Review Literature as Topic | 1 | 2017 | 347 | 0.500 |
Why?
|
| Financing, Personal | 2 | 2015 | 308 | 0.500 |
Why?
|
| Sex Factors | 30 | 2024 | 10552 | 0.490 |
Why?
|
| Longitudinal Studies | 38 | 2024 | 14607 | 0.490 |
Why?
|
| Uric Acid | 6 | 2017 | 806 | 0.490 |
Why?
|
| Diet Surveys | 13 | 2021 | 1161 | 0.490 |
Why?
|
| Transportation | 1 | 2016 | 217 | 0.490 |
Why?
|
| Quantitative Trait, Heritable | 5 | 2019 | 540 | 0.480 |
Why?
|
| Antihypertensive Agents | 8 | 2022 | 2019 | 0.480 |
Why?
|
| Epigenomics | 7 | 2024 | 943 | 0.480 |
Why?
|
| Galectin 3 | 1 | 2016 | 240 | 0.480 |
Why?
|
| Body Fat Distribution | 6 | 2016 | 245 | 0.470 |
Why?
|
| Drug Combinations | 3 | 2012 | 2048 | 0.470 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2016 | 698 | 0.470 |
Why?
|
| Bilirubin | 1 | 2016 | 435 | 0.470 |
Why?
|
| Perimenopause | 2 | 2015 | 142 | 0.460 |
Why?
|
| Multivariate Analysis | 22 | 2019 | 12058 | 0.460 |
Why?
|
| Pregnancy Proteins | 1 | 2015 | 222 | 0.460 |
Why?
|
| Mental Health | 9 | 2024 | 3251 | 0.460 |
Why?
|
| Phytotherapy | 1 | 2016 | 296 | 0.460 |
Why?
|
| Magnesium | 7 | 2017 | 804 | 0.460 |
Why?
|
| Beverages | 5 | 2017 | 821 | 0.450 |
Why?
|
| Politics | 1 | 2020 | 814 | 0.450 |
Why?
|
| Streptococcus pneumoniae | 1 | 2019 | 730 | 0.450 |
Why?
|
| Inhalation Exposure | 1 | 2016 | 432 | 0.450 |
Why?
|
| Child | 78 | 2023 | 80134 | 0.440 |
Why?
|
| Coronavirus | 3 | 2020 | 156 | 0.440 |
Why?
|
| Genome, Human | 12 | 2018 | 4423 | 0.440 |
Why?
|
| Cognition | 11 | 2024 | 6987 | 0.440 |
Why?
|
| Walking | 2 | 2018 | 1194 | 0.440 |
Why?
|
| Phenotype | 27 | 2024 | 16572 | 0.440 |
Why?
|
| Risk | 21 | 2021 | 9614 | 0.440 |
Why?
|
| Vitamins | 4 | 2017 | 1634 | 0.440 |
Why?
|
| Quality-Adjusted Life Years | 4 | 2022 | 1723 | 0.440 |
Why?
|
| Gene Frequency | 16 | 2018 | 3603 | 0.430 |
Why?
|
| Choline | 1 | 2015 | 515 | 0.430 |
Why?
|
| Delivery of Health Care | 4 | 2022 | 5333 | 0.430 |
Why?
|
| Albuminuria | 8 | 2019 | 656 | 0.430 |
Why?
|
| Motor Skills | 1 | 2016 | 521 | 0.420 |
Why?
|
| Pre-Eclampsia | 2 | 2020 | 1231 | 0.420 |
Why?
|
| Income | 4 | 2023 | 1868 | 0.420 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 9 | 2019 | 3200 | 0.420 |
Why?
|
| Child, Preschool | 48 | 2020 | 42217 | 0.420 |
Why?
|
| Troponin T | 2 | 2023 | 780 | 0.420 |
Why?
|
| gamma-Glutamyltransferase | 3 | 2017 | 144 | 0.420 |
Why?
|
| Diet Records | 7 | 2019 | 427 | 0.420 |
Why?
|
| Thyroid Hormones | 5 | 2020 | 403 | 0.410 |
Why?
|
| Cacao | 2 | 2011 | 98 | 0.410 |
Why?
|
| Creatinine | 9 | 2022 | 1897 | 0.410 |
Why?
|
| Women's Health | 4 | 2018 | 2068 | 0.410 |
Why?
|
| Women's Rights | 1 | 2013 | 65 | 0.410 |
Why?
|
| Human Development | 1 | 2013 | 123 | 0.410 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2016 | 1488 | 0.410 |
Why?
|
| Calcium, Dietary | 4 | 2016 | 529 | 0.410 |
Why?
|
| Carotid Artery, Common | 4 | 2018 | 175 | 0.410 |
Why?
|
| Tablets | 1 | 2012 | 148 | 0.400 |
Why?
|
| Vitamin B 12 | 5 | 2018 | 524 | 0.400 |
Why?
|
| Epidemiologic Research Design | 5 | 2017 | 368 | 0.390 |
Why?
|
| Biological Specimen Banks | 3 | 2024 | 778 | 0.390 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2019 | 1048 | 0.390 |
Why?
|
| Infant | 42 | 2020 | 36164 | 0.390 |
Why?
|
| Preventive Medicine | 2 | 2015 | 245 | 0.390 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2015 | 558 | 0.390 |
Why?
|
| Myocardial Infarction | 19 | 2022 | 11475 | 0.380 |
Why?
|
| Mothers | 12 | 2019 | 2193 | 0.380 |
Why?
|
| Life Tables | 3 | 2019 | 364 | 0.380 |
Why?
|
| Students | 1 | 2021 | 1737 | 0.380 |
Why?
|
| Neurodegenerative Diseases | 2 | 2018 | 1085 | 0.370 |
Why?
|
| Waist-Hip Ratio | 7 | 2018 | 518 | 0.370 |
Why?
|
| Dietary Fiber | 6 | 2017 | 758 | 0.370 |
Why?
|
| Comorbidity | 19 | 2020 | 10514 | 0.360 |
Why?
|
| Nutritional Status | 8 | 2019 | 1597 | 0.360 |
Why?
|
| Lung Diseases | 2 | 2018 | 1909 | 0.360 |
Why?
|
| Philosophy, Medical | 1 | 2011 | 79 | 0.360 |
Why?
|
| Body Weight | 12 | 2019 | 4618 | 0.360 |
Why?
|
| Depression | 13 | 2021 | 8130 | 0.360 |
Why?
|
| Pericardium | 4 | 2022 | 674 | 0.360 |
Why?
|
| Vitamin K Deficiency | 1 | 2010 | 24 | 0.350 |
Why?
|
| Family Characteristics | 2 | 2014 | 992 | 0.350 |
Why?
|
| Respiratory Tract Diseases | 1 | 2016 | 748 | 0.350 |
Why?
|
| Heart Diseases | 7 | 2018 | 2795 | 0.350 |
Why?
|
| Logistic Models | 20 | 2020 | 13254 | 0.350 |
Why?
|
| Actigraphy | 4 | 2019 | 522 | 0.340 |
Why?
|
| Migraine Disorders | 3 | 2019 | 1701 | 0.340 |
Why?
|
| Spinal Cord Injuries | 3 | 2022 | 924 | 0.340 |
Why?
|
| Time Factors | 32 | 2024 | 39953 | 0.340 |
Why?
|
| Constipation | 1 | 2014 | 564 | 0.340 |
Why?
|
| Macular Degeneration | 4 | 2018 | 1008 | 0.340 |
Why?
|
| Sarcopenia | 3 | 2019 | 370 | 0.340 |
Why?
|
| Social Values | 1 | 2011 | 225 | 0.340 |
Why?
|
| Dietary Sucrose | 3 | 2017 | 243 | 0.340 |
Why?
|
| Depressive Disorder, Major | 3 | 2024 | 4766 | 0.330 |
Why?
|
| Osteoporotic Fractures | 5 | 2019 | 410 | 0.330 |
Why?
|
| Health Status Disparities | 7 | 2024 | 1846 | 0.330 |
Why?
|
| Kidney Diseases | 6 | 2019 | 2092 | 0.330 |
Why?
|
| Nutrition Surveys | 9 | 2024 | 1722 | 0.320 |
Why?
|
| CpG Islands | 9 | 2020 | 1190 | 0.320 |
Why?
|
| Hypertension, Pulmonary | 5 | 2017 | 1585 | 0.320 |
Why?
|
| Diet, Vegetarian | 3 | 2022 | 180 | 0.320 |
Why?
|
| Epistasis, Genetic | 5 | 2018 | 350 | 0.320 |
Why?
|
| Alleles | 16 | 2019 | 6857 | 0.320 |
Why?
|
| Kidney Function Tests | 8 | 2019 | 680 | 0.320 |
Why?
|
| Urban Health | 4 | 2023 | 532 | 0.320 |
Why?
|
| Fibrinolytic Agents | 1 | 2018 | 2075 | 0.320 |
Why?
|
| Hyperglycemia | 4 | 2022 | 1375 | 0.310 |
Why?
|
| Lignans | 2 | 2009 | 84 | 0.310 |
Why?
|
| Homeostasis | 6 | 2024 | 3318 | 0.310 |
Why?
|
| Practice Guidelines as Topic | 5 | 2020 | 7400 | 0.310 |
Why?
|
| Physical Fitness | 3 | 2013 | 742 | 0.310 |
Why?
|
| Dehydroepiandrosterone Sulfate | 4 | 2024 | 241 | 0.310 |
Why?
|
| Self Disclosure | 1 | 2009 | 249 | 0.310 |
Why?
|
| Pregnancy Trimester, First | 5 | 2017 | 908 | 0.310 |
Why?
|
| Odds Ratio | 19 | 2019 | 9648 | 0.300 |
Why?
|
| Disease Progression | 13 | 2024 | 13506 | 0.300 |
Why?
|
| Coffee | 4 | 2017 | 592 | 0.300 |
Why?
|
| Air Pollution | 5 | 2024 | 2351 | 0.300 |
Why?
|
| Inflammation | 11 | 2018 | 10758 | 0.300 |
Why?
|
| MicroRNAs | 8 | 2018 | 3758 | 0.300 |
Why?
|
| Sex Characteristics | 8 | 2024 | 2638 | 0.290 |
Why?
|
| Employment | 4 | 2015 | 1114 | 0.290 |
Why?
|
| Aorta, Thoracic | 6 | 2022 | 1096 | 0.290 |
Why?
|
| Executive Function | 1 | 2016 | 1388 | 0.290 |
Why?
|
| Goals | 1 | 2013 | 708 | 0.290 |
Why?
|
| Pulmonary Diffusing Capacity | 2 | 2017 | 94 | 0.290 |
Why?
|
| Gait | 3 | 2018 | 810 | 0.290 |
Why?
|
| Population Dynamics | 3 | 2015 | 308 | 0.290 |
Why?
|
| Calcinosis | 4 | 2017 | 1477 | 0.290 |
Why?
|
| Prognosis | 29 | 2021 | 29672 | 0.280 |
Why?
|
| Guidelines as Topic | 4 | 2019 | 1386 | 0.280 |
Why?
|
| Heart | 4 | 2023 | 4431 | 0.280 |
Why?
|
| Genetic Pleiotropy | 4 | 2019 | 181 | 0.280 |
Why?
|
| Genotype | 24 | 2019 | 12983 | 0.280 |
Why?
|
| Fetus | 5 | 2020 | 1862 | 0.280 |
Why?
|
| Alcoholism | 1 | 2018 | 1973 | 0.280 |
Why?
|
| Emergencies | 2 | 2024 | 1217 | 0.280 |
Why?
|
| Meat Products | 2 | 2019 | 96 | 0.280 |
Why?
|
| Carotid Stenosis | 5 | 2017 | 859 | 0.280 |
Why?
|
| Cardiovascular Agents | 1 | 2013 | 842 | 0.280 |
Why?
|
| Cardiology | 6 | 2022 | 1693 | 0.280 |
Why?
|
| Predictive Value of Tests | 17 | 2023 | 15308 | 0.280 |
Why?
|
| Health Promotion | 3 | 2014 | 2205 | 0.270 |
Why?
|
| Metabolism | 2 | 2018 | 193 | 0.270 |
Why?
|
| United States | 39 | 2024 | 72337 | 0.270 |
Why?
|
| Chromosome Mapping | 7 | 2019 | 4612 | 0.270 |
Why?
|
| Feeding Methods | 2 | 2017 | 35 | 0.270 |
Why?
|
| Anticholesteremic Agents | 3 | 2019 | 968 | 0.270 |
Why?
|
| Evidence-Based Medicine | 2 | 2016 | 3689 | 0.270 |
Why?
|
| Venous Thromboembolism | 3 | 2019 | 1868 | 0.270 |
Why?
|
| Long QT Syndrome | 3 | 2015 | 466 | 0.270 |
Why?
|
| Cognition Disorders | 4 | 2015 | 3974 | 0.270 |
Why?
|
| Fasting | 6 | 2019 | 1603 | 0.260 |
Why?
|
| Fruit | 7 | 2019 | 1158 | 0.260 |
Why?
|
| Suriname | 2 | 2023 | 28 | 0.260 |
Why?
|
| Models, Biological | 3 | 2019 | 9455 | 0.260 |
Why?
|
| Brain | 12 | 2022 | 27097 | 0.260 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 3 | 2017 | 160 | 0.260 |
Why?
|
| Homocysteine | 3 | 2018 | 637 | 0.250 |
Why?
|
| Randomized Controlled Trials as Topic | 13 | 2020 | 10213 | 0.250 |
Why?
|
| Water-Electrolyte Imbalance | 2 | 2017 | 109 | 0.250 |
Why?
|
| Primary Ovarian Insufficiency | 2 | 2016 | 107 | 0.250 |
Why?
|
| Young Adult | 30 | 2022 | 59199 | 0.250 |
Why?
|
| Carotid Artery, Internal | 3 | 2019 | 445 | 0.250 |
Why?
|
| Reference Values | 5 | 2019 | 4922 | 0.240 |
Why?
|
| Internationality | 3 | 2015 | 1000 | 0.240 |
Why?
|
| China | 13 | 2009 | 2374 | 0.240 |
Why?
|
| Factor VIII | 2 | 2019 | 349 | 0.240 |
Why?
|
| Residence Characteristics | 1 | 2014 | 2092 | 0.240 |
Why?
|
| Pulmonary Artery | 3 | 2017 | 1927 | 0.230 |
Why?
|
| Thyroid Neoplasms | 1 | 2018 | 2331 | 0.230 |
Why?
|
| Carotenoids | 3 | 2016 | 621 | 0.230 |
Why?
|
| Abdominal Fat | 3 | 2015 | 221 | 0.230 |
Why?
|
| Hip Fractures | 4 | 2016 | 989 | 0.230 |
Why?
|
| Fibroblast Growth Factors | 4 | 2018 | 863 | 0.230 |
Why?
|
| Morocco | 1 | 2023 | 30 | 0.230 |
Why?
|
| Osteoporosis | 5 | 2019 | 1604 | 0.230 |
Why?
|
| Epidemiologic Studies | 2 | 2019 | 673 | 0.230 |
Why?
|
| Survival Rate | 11 | 2020 | 12727 | 0.230 |
Why?
|
| Age Distribution | 8 | 2016 | 2873 | 0.220 |
Why?
|
| Heart Conduction System | 3 | 2018 | 1008 | 0.220 |
Why?
|
| Parity | 3 | 2016 | 924 | 0.220 |
Why?
|
| Systole | 7 | 2022 | 936 | 0.220 |
Why?
|
| Depressive Disorder | 6 | 2016 | 3727 | 0.220 |
Why?
|
| Body Size | 2 | 2017 | 463 | 0.220 |
Why?
|
| Research Design | 5 | 2017 | 6178 | 0.220 |
Why?
|
| Iron | 3 | 2020 | 1790 | 0.220 |
Why?
|
| Parenting | 3 | 2019 | 701 | 0.220 |
Why?
|
| Pelvic Bones | 2 | 2015 | 270 | 0.210 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2018 | 702 | 0.210 |
Why?
|
| Magnetic Resonance Angiography | 4 | 2017 | 1432 | 0.210 |
Why?
|
| Trace Elements | 2 | 2016 | 193 | 0.210 |
Why?
|
| Blood Coagulation | 2 | 2019 | 1156 | 0.210 |
Why?
|
| Bone Development | 2 | 2017 | 470 | 0.210 |
Why?
|
| Pregnancy Outcome | 5 | 2020 | 2920 | 0.210 |
Why?
|
| Maternal Exposure | 3 | 2018 | 1067 | 0.210 |
Why?
|
| Birth Weight | 4 | 2019 | 2101 | 0.210 |
Why?
|
| Androstenedione | 3 | 2018 | 131 | 0.210 |
Why?
|
| Selenium | 2 | 2023 | 416 | 0.200 |
Why?
|
| Insurance | 1 | 2024 | 113 | 0.200 |
Why?
|
| Eczema | 2 | 2016 | 246 | 0.200 |
Why?
|
| Hyperphosphatemia | 1 | 2022 | 38 | 0.200 |
Why?
|
| Diabetic Neuropathies | 2 | 2016 | 406 | 0.200 |
Why?
|
| Asymptomatic Diseases | 5 | 2017 | 588 | 0.200 |
Why?
|
| Fatty Liver | 3 | 2017 | 789 | 0.200 |
Why?
|
| Relief Work | 1 | 2023 | 130 | 0.200 |
Why?
|
| Retinal Vessels | 3 | 2017 | 854 | 0.200 |
Why?
|
| Nerve Tissue Proteins | 6 | 2017 | 4405 | 0.200 |
Why?
|
| Neglected Diseases | 1 | 2022 | 66 | 0.200 |
Why?
|
| Mother-Child Relations | 2 | 2017 | 495 | 0.200 |
Why?
|
| Bone and Bones | 4 | 2017 | 2567 | 0.190 |
Why?
|
| Receptors, Calcitriol | 1 | 2024 | 360 | 0.190 |
Why?
|
| Colorectal Neoplasms | 3 | 2016 | 6919 | 0.190 |
Why?
|
| Respiratory Sounds | 3 | 2016 | 702 | 0.190 |
Why?
|
| Personal Satisfaction | 2 | 2017 | 645 | 0.190 |
Why?
|
| Medication Adherence | 1 | 2013 | 2175 | 0.190 |
Why?
|
| Regression Analysis | 9 | 2021 | 6343 | 0.190 |
Why?
|
| Coronary Vessels | 5 | 2022 | 3111 | 0.190 |
Why?
|
| Primary Health Care | 3 | 2018 | 4673 | 0.190 |
Why?
|
| Computational Biology | 5 | 2022 | 3499 | 0.190 |
Why?
|
| Animals | 30 | 2024 | 168083 | 0.190 |
Why?
|
| Food | 2 | 2024 | 768 | 0.190 |
Why?
|
| Heart Injuries | 1 | 2023 | 206 | 0.190 |
Why?
|
| Glucose | 5 | 2022 | 4341 | 0.190 |
Why?
|
| Eggs | 2 | 2020 | 182 | 0.190 |
Why?
|
| Myocardium | 6 | 2022 | 4746 | 0.190 |
Why?
|
| Anxiety | 4 | 2023 | 4572 | 0.190 |
Why?
|
| Software | 2 | 2023 | 4433 | 0.190 |
Why?
|
| Estrogens | 2 | 2019 | 1521 | 0.180 |
Why?
|
| Fetal Blood | 3 | 2017 | 1347 | 0.180 |
Why?
|
| Renal Insufficiency | 2 | 2018 | 808 | 0.180 |
Why?
|
| Liver | 5 | 2020 | 7513 | 0.180 |
Why?
|
| Intelligence | 2 | 2017 | 922 | 0.180 |
Why?
|
| Fetal Development | 3 | 2016 | 768 | 0.180 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 7405 | 0.180 |
Why?
|
| Anemia | 3 | 2020 | 1504 | 0.180 |
Why?
|
| Diet, Fat-Restricted | 3 | 2018 | 329 | 0.180 |
Why?
|
| Infant, Low Birth Weight | 2 | 2017 | 869 | 0.180 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2018 | 2746 | 0.180 |
Why?
|
| Polymorphism, Genetic | 4 | 2024 | 4243 | 0.180 |
Why?
|
| Thoracic Injuries | 1 | 2023 | 288 | 0.180 |
Why?
|
| Cross-Cultural Comparison | 3 | 2017 | 634 | 0.180 |
Why?
|
| Case-Control Studies | 13 | 2018 | 22157 | 0.180 |
Why?
|
| Sex Distribution | 6 | 2018 | 2278 | 0.180 |
Why?
|
| 3' Untranslated Regions | 3 | 2017 | 514 | 0.170 |
Why?
|
| Aortography | 2 | 2019 | 421 | 0.170 |
Why?
|
| Pregnant Women | 2 | 2015 | 567 | 0.170 |
Why?
|
| Menu Planning | 1 | 2020 | 28 | 0.170 |
Why?
|
| Infant, Newborn | 16 | 2019 | 26187 | 0.170 |
Why?
|
| Echocardiography | 5 | 2020 | 5006 | 0.170 |
Why?
|
| Gene Expression Regulation | 13 | 2019 | 11856 | 0.170 |
Why?
|
| Hyperemesis Gravidarum | 1 | 2019 | 23 | 0.170 |
Why?
|
| Heart Failure | 12 | 2021 | 11701 | 0.170 |
Why?
|
| Maternal Age | 3 | 2019 | 809 | 0.170 |
Why?
|
| Uromodulin | 2 | 2019 | 44 | 0.160 |
Why?
|
| Hypolipidemic Agents | 2 | 2015 | 609 | 0.160 |
Why?
|
| Universities | 2 | 2021 | 995 | 0.160 |
Why?
|
| Chile | 1 | 2020 | 256 | 0.160 |
Why?
|
| Cost-Benefit Analysis | 6 | 2015 | 5494 | 0.160 |
Why?
|
| Blood Coagulation Disorders, Inherited | 1 | 2019 | 19 | 0.160 |
Why?
|
| Neural Conduction | 2 | 2017 | 441 | 0.160 |
Why?
|
| Genes, Mitochondrial | 1 | 2018 | 58 | 0.160 |
Why?
|
| Brain Ischemia | 5 | 2019 | 3031 | 0.160 |
Why?
|
| Aorta | 2 | 2017 | 2040 | 0.160 |
Why?
|
| Cotinine | 1 | 2019 | 206 | 0.160 |
Why?
|
| RNA-Binding Proteins | 2 | 2018 | 1855 | 0.160 |
Why?
|
| Sodium, Dietary | 1 | 2022 | 425 | 0.160 |
Why?
|
| Obesity, Abdominal | 2 | 2019 | 373 | 0.160 |
Why?
|
| Fats | 1 | 2019 | 99 | 0.160 |
Why?
|
| Diastole | 5 | 2022 | 782 | 0.160 |
Why?
|
| Phosphates | 2 | 2022 | 763 | 0.160 |
Why?
|
| Calcium | 4 | 2018 | 5720 | 0.150 |
Why?
|
| Temperature | 2 | 2023 | 2219 | 0.150 |
Why?
|
| Reproduction | 1 | 2023 | 646 | 0.150 |
Why?
|
| Adolescent | 20 | 2024 | 88271 | 0.150 |
Why?
|
| Parkinson Disease | 3 | 2017 | 2869 | 0.150 |
Why?
|
| Dermatitis, Seborrheic | 1 | 2017 | 7 | 0.150 |
Why?
|
| Asia | 3 | 2016 | 621 | 0.150 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2019 | 175 | 0.150 |
Why?
|
| Denmark | 1 | 2020 | 770 | 0.150 |
Why?
|
| Atrial Function | 1 | 2018 | 99 | 0.150 |
Why?
|
| Cold Temperature | 1 | 2022 | 783 | 0.150 |
Why?
|
| Alcoholic Beverages | 2 | 2017 | 264 | 0.150 |
Why?
|
| Acidosis | 2 | 2017 | 268 | 0.150 |
Why?
|
| Neoplasms | 12 | 2023 | 22125 | 0.150 |
Why?
|
| Phospholipids | 1 | 2022 | 784 | 0.150 |
Why?
|
| Asthma | 6 | 2016 | 6229 | 0.150 |
Why?
|
| Micronutrients | 2 | 2018 | 381 | 0.150 |
Why?
|
| Survival Analysis | 9 | 2019 | 10083 | 0.150 |
Why?
|
| Kaplan-Meier Estimate | 6 | 2019 | 6482 | 0.150 |
Why?
|
| Muscular Diseases | 1 | 2022 | 552 | 0.150 |
Why?
|
| Atrioventricular Node | 1 | 2018 | 180 | 0.150 |
Why?
|
| Drug Implants | 1 | 2018 | 230 | 0.150 |
Why?
|
| Pulmonary Heart Disease | 1 | 2017 | 34 | 0.140 |
Why?
|
| Anxiety Disorders | 2 | 2022 | 2723 | 0.140 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2018 | 88 | 0.140 |
Why?
|
| Cerebrovascular Circulation | 3 | 2017 | 2725 | 0.140 |
Why?
|
| Inflammation Mediators | 4 | 2014 | 1885 | 0.140 |
Why?
|
| Search Engine | 1 | 2018 | 142 | 0.140 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2019 | 790 | 0.140 |
Why?
|
| Proinsulin | 1 | 2017 | 135 | 0.140 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2017 | 37 | 0.140 |
Why?
|
| Sodium-Bicarbonate Symporters | 1 | 2017 | 30 | 0.140 |
Why?
|
| Environmental Pollution | 1 | 2018 | 124 | 0.140 |
Why?
|
| Cardiomyopathies | 2 | 2022 | 2021 | 0.140 |
Why?
|
| American Heart Association | 3 | 2021 | 1043 | 0.140 |
Why?
|
| Disabled Persons | 3 | 2014 | 1226 | 0.140 |
Why?
|
| Son of Sevenless Proteins | 1 | 2016 | 27 | 0.140 |
Why?
|
| Metals, Heavy | 1 | 2018 | 148 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 16 | 2020 | 36418 | 0.140 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2016 | 3776 | 0.140 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 2017 | 101 | 0.140 |
Why?
|
| Dextrothyroxine | 1 | 2016 | 6 | 0.140 |
Why?
|
| Health Priorities | 1 | 2020 | 375 | 0.140 |
Why?
|
| beta Carotene | 2 | 2015 | 523 | 0.140 |
Why?
|
| Psoriasis | 2 | 2017 | 945 | 0.140 |
Why?
|
| Health Surveys | 6 | 2015 | 4036 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 4 | 2 | 2017 | 375 | 0.140 |
Why?
|
| Feeding and Eating Disorders of Childhood | 1 | 2017 | 42 | 0.140 |
Why?
|
| Heart Rate | 4 | 2017 | 4196 | 0.140 |
Why?
|
| Bayes Theorem | 4 | 2017 | 2327 | 0.140 |
Why?
|
| Emotions | 3 | 2019 | 2740 | 0.140 |
Why?
|
| Urban Population | 4 | 2014 | 2035 | 0.140 |
Why?
|
| Islets of Langerhans | 2 | 2024 | 1341 | 0.140 |
Why?
|
| Aortic Valve | 2 | 2017 | 1959 | 0.140 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2023 | 806 | 0.140 |
Why?
|
| Bronchitis, Chronic | 1 | 2017 | 82 | 0.140 |
Why?
|
| Organ Size | 6 | 2019 | 2253 | 0.140 |
Why?
|
| Linkage Disequilibrium | 6 | 2018 | 1995 | 0.140 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 2 | 2017 | 173 | 0.140 |
Why?
|
| India | 5 | 2016 | 2287 | 0.130 |
Why?
|
| Electrophysiological Phenomena | 1 | 2018 | 307 | 0.130 |
Why?
|
| Data Interpretation, Statistical | 2 | 2016 | 2691 | 0.130 |
Why?
|
| Axial Length, Eye | 1 | 2016 | 35 | 0.130 |
Why?
|
| Gardening | 1 | 2016 | 18 | 0.130 |
Why?
|
| Fibrosis | 2 | 2022 | 2051 | 0.130 |
Why?
|
| Propylthiouracil | 1 | 2016 | 68 | 0.130 |
Why?
|
| Area Under Curve | 2 | 2019 | 1636 | 0.130 |
Why?
|
| Lactation | 2 | 2016 | 397 | 0.130 |
Why?
|
| Community Health Planning | 4 | 2017 | 164 | 0.130 |
Why?
|
| Sodium | 2 | 2022 | 1589 | 0.130 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2016 | 118 | 0.130 |
Why?
|
| Vitamin K | 1 | 2018 | 313 | 0.130 |
Why?
|
| Haplotypes | 3 | 2017 | 2714 | 0.130 |
Why?
|
| Elder Nutritional Physiological Phenomena | 1 | 2015 | 7 | 0.130 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 1 | 1 | 2015 | 6 | 0.130 |
Why?
|
| Arrhythmias, Cardiac | 4 | 2018 | 2247 | 0.130 |
Why?
|
| Health Personnel | 2 | 2021 | 3335 | 0.130 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2017 | 118 | 0.130 |
Why?
|
| Skinfold Thickness | 1 | 2016 | 163 | 0.130 |
Why?
|
| Histone Code | 1 | 2016 | 158 | 0.130 |
Why?
|
| Magnesium Deficiency | 1 | 2016 | 48 | 0.130 |
Why?
|
| Angiopoietins | 1 | 2016 | 86 | 0.130 |
Why?
|
| Acid-Base Imbalance | 1 | 2015 | 41 | 0.130 |
Why?
|
| Guideline Adherence | 2 | 2017 | 2218 | 0.130 |
Why?
|
| Diabetic Angiopathies | 2 | 2024 | 805 | 0.130 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2016 | 113 | 0.130 |
Why?
|
| Alu Elements | 1 | 2016 | 115 | 0.130 |
Why?
|
| Shear Strength | 1 | 2016 | 160 | 0.130 |
Why?
|
| Aspartate Aminotransferases | 1 | 2017 | 411 | 0.130 |
Why?
|
| Myocardial Revascularization | 1 | 2019 | 794 | 0.130 |
Why?
|
| Infant Nutrition Disorders | 1 | 2016 | 70 | 0.130 |
Why?
|
| Hemostasis | 1 | 2018 | 470 | 0.130 |
Why?
|
| Alzheimer Disease | 6 | 2022 | 8601 | 0.130 |
Why?
|
| Femur Neck | 5 | 2016 | 315 | 0.130 |
Why?
|
| Pharmacogenetics | 2 | 2016 | 675 | 0.130 |
Why?
|
| Histidine Ammonia-Lyase | 1 | 2015 | 9 | 0.120 |
Why?
|
| Hot Temperature | 1 | 2022 | 1434 | 0.120 |
Why?
|
| Vaginal Diseases | 1 | 2016 | 103 | 0.120 |
Why?
|
| Fractional Flow Reserve, Myocardial | 1 | 2019 | 345 | 0.120 |
Why?
|
| Receptors, Cytokine | 1 | 2016 | 257 | 0.120 |
Why?
|
| Hip | 1 | 2016 | 255 | 0.120 |
Why?
|
| Demography | 1 | 2020 | 1643 | 0.120 |
Why?
|
| Venules | 1 | 2015 | 161 | 0.120 |
Why?
|
| Morbidity | 2 | 2018 | 1750 | 0.120 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 316 | 0.120 |
Why?
|
| Occupations | 1 | 2017 | 516 | 0.120 |
Why?
|
| Sweetening Agents | 1 | 2017 | 290 | 0.120 |
Why?
|
| Transcription Factors | 5 | 2018 | 12096 | 0.120 |
Why?
|
| Injections | 1 | 2018 | 832 | 0.120 |
Why?
|
| Calcification, Physiologic | 1 | 2015 | 170 | 0.120 |
Why?
|
| Factor VII | 1 | 2015 | 139 | 0.120 |
Why?
|
| Grief | 1 | 2017 | 254 | 0.120 |
Why?
|
| Severity of Illness Index | 10 | 2017 | 15845 | 0.120 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2015 | 563 | 0.120 |
Why?
|
| Somatotypes | 1 | 2014 | 41 | 0.120 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2014 | 63 | 0.120 |
Why?
|
| Data Collection | 3 | 2014 | 3319 | 0.120 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2016 | 431 | 0.120 |
Why?
|
| Taste | 1 | 2016 | 189 | 0.120 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2019 | 749 | 0.120 |
Why?
|
| Progesterone | 1 | 2019 | 742 | 0.120 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2016 | 304 | 0.120 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2016 | 456 | 0.120 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2017 | 461 | 0.120 |
Why?
|
| Physical Examination | 3 | 2017 | 1255 | 0.120 |
Why?
|
| Digoxin | 1 | 2015 | 246 | 0.120 |
Why?
|
| Bicycling | 1 | 2016 | 177 | 0.120 |
Why?
|
| Apolipoproteins | 1 | 2016 | 327 | 0.120 |
Why?
|
| Arterioles | 1 | 2015 | 250 | 0.120 |
Why?
|
| Chloride Channels | 1 | 2015 | 221 | 0.120 |
Why?
|
| Lung | 3 | 2020 | 9979 | 0.120 |
Why?
|
| Alanine Transaminase | 1 | 2017 | 602 | 0.120 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2017 | 348 | 0.120 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 2016 | 190 | 0.120 |
Why?
|
| Inflammasomes | 1 | 2019 | 525 | 0.120 |
Why?
|
| Ferritins | 3 | 2020 | 597 | 0.120 |
Why?
|
| Coronary Angiography | 4 | 2019 | 4506 | 0.110 |
Why?
|
| Parkinsonian Disorders | 1 | 2017 | 285 | 0.110 |
Why?
|
| Syntaxin 1 | 1 | 2014 | 29 | 0.110 |
Why?
|
| Nervous System Diseases | 2 | 2022 | 1663 | 0.110 |
Why?
|
| Neurology | 1 | 2022 | 784 | 0.110 |
Why?
|
| Aortic Valve Stenosis | 2 | 2017 | 2018 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2016 | 4510 | 0.110 |
Why?
|
| Histidine | 1 | 2015 | 303 | 0.110 |
Why?
|
| R-SNARE Proteins | 1 | 2014 | 73 | 0.110 |
Why?
|
| Lipase | 1 | 2016 | 324 | 0.110 |
Why?
|
| Anticarcinogenic Agents | 1 | 2015 | 249 | 0.110 |
Why?
|
| Histamine H2 Antagonists | 1 | 2015 | 166 | 0.110 |
Why?
|
| S100 Proteins | 1 | 2014 | 216 | 0.110 |
Why?
|
| Diet, Mediterranean | 2 | 2018 | 738 | 0.110 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2014 | 113 | 0.110 |
Why?
|
| Cell Membrane Permeability | 1 | 2016 | 573 | 0.110 |
Why?
|
| Models, Cardiovascular | 1 | 2019 | 983 | 0.110 |
Why?
|
| Sickness Impact Profile | 1 | 2015 | 299 | 0.110 |
Why?
|
| Leukocyte Count | 2 | 2014 | 1597 | 0.110 |
Why?
|
| Membrane Transport Proteins | 2 | 2016 | 1033 | 0.110 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2017 | 561 | 0.110 |
Why?
|
| Aortic Diseases | 2 | 2019 | 735 | 0.110 |
Why?
|
| Phospholipases A2, Secretory | 1 | 2013 | 30 | 0.110 |
Why?
|
| Fetal Growth Retardation | 2 | 2016 | 580 | 0.110 |
Why?
|
| Plasma | 1 | 2017 | 586 | 0.110 |
Why?
|
| ADAM Proteins | 1 | 2015 | 238 | 0.110 |
Why?
|
| Milk, Human | 2 | 2015 | 486 | 0.110 |
Why?
|
| Energy Metabolism | 4 | 2018 | 2877 | 0.110 |
Why?
|
| Sequence Analysis, DNA | 4 | 2017 | 4739 | 0.110 |
Why?
|
| Happiness | 1 | 2015 | 170 | 0.110 |
Why?
|
| Retinol-Binding Proteins, Plasma | 3 | 2009 | 94 | 0.110 |
Why?
|
| Coronary Stenosis | 1 | 2019 | 802 | 0.110 |
Why?
|
| DNA, Mitochondrial | 1 | 2018 | 865 | 0.110 |
Why?
|
| Exons | 2 | 2016 | 2380 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2009 | 3429 | 0.110 |
Why?
|
| Suburban Health | 1 | 2013 | 11 | 0.110 |
Why?
|
| Acetylation | 1 | 2016 | 1050 | 0.110 |
Why?
|
| Myopia | 1 | 2016 | 252 | 0.110 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2015 | 240 | 0.110 |
Why?
|
| Osteoarthritis, Knee | 2 | 2015 | 1235 | 0.110 |
Why?
|
| CD40 Ligand | 1 | 2015 | 524 | 0.110 |
Why?
|
| Environment | 3 | 2016 | 1121 | 0.110 |
Why?
|
| Political Systems | 1 | 2013 | 23 | 0.110 |
Why?
|
| Markov Chains | 1 | 2016 | 965 | 0.110 |
Why?
|
| Age of Onset | 2 | 2019 | 3307 | 0.110 |
Why?
|
| Genetic Markers | 5 | 2019 | 2599 | 0.110 |
Why?
|
| Glutamic Acid | 2 | 2015 | 1173 | 0.110 |
Why?
|
| Multifactorial Inheritance | 2 | 2024 | 1381 | 0.110 |
Why?
|
| Reproducibility of Results | 10 | 2019 | 20120 | 0.110 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2014 | 138 | 0.100 |
Why?
|
| DNA | 2 | 2019 | 7189 | 0.100 |
Why?
|
| Spirometry | 4 | 2017 | 928 | 0.100 |
Why?
|
| Spinal Fractures | 1 | 2019 | 704 | 0.100 |
Why?
|
| Methionine | 1 | 2015 | 570 | 0.100 |
Why?
|
| Registries | 3 | 2021 | 8236 | 0.100 |
Why?
|
| Erythropoiesis | 1 | 2016 | 683 | 0.100 |
Why?
|
| Microvessels | 1 | 2017 | 580 | 0.100 |
Why?
|
| Bulimia Nervosa | 1 | 2014 | 205 | 0.100 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2015 | 691 | 0.100 |
Why?
|
| Hematologic Diseases | 1 | 2016 | 496 | 0.100 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2015 | 730 | 0.100 |
Why?
|
| Body Image | 1 | 2017 | 639 | 0.100 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2014 | 127 | 0.100 |
Why?
|
| Philosophy | 1 | 2012 | 69 | 0.100 |
Why?
|
| Hyperinsulinism | 1 | 2015 | 400 | 0.100 |
Why?
|
| Subcutaneous Fat | 1 | 2016 | 393 | 0.100 |
Why?
|
| Concept Formation | 1 | 2013 | 161 | 0.100 |
Why?
|
| Adiponectin | 5 | 2009 | 1106 | 0.100 |
Why?
|
| Lipoprotein Lipase | 1 | 2012 | 133 | 0.100 |
Why?
|
| Mutation, Missense | 3 | 2018 | 2567 | 0.100 |
Why?
|
| Vitamin A | 1 | 2015 | 612 | 0.100 |
Why?
|
| Hypokalemia | 1 | 2013 | 153 | 0.100 |
Why?
|
| Pulmonary Ventilation | 1 | 2014 | 372 | 0.100 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2019 | 1208 | 0.100 |
Why?
|
| Confidence Intervals | 5 | 2021 | 2927 | 0.100 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2017 | 1803 | 0.100 |
Why?
|
| Complementary Therapies | 1 | 2016 | 486 | 0.100 |
Why?
|
| Mind-Body Therapies | 1 | 2015 | 280 | 0.100 |
Why?
|
| United Nations | 1 | 2013 | 148 | 0.100 |
Why?
|
| Receptors, Nicotinic | 1 | 2015 | 494 | 0.100 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2016 | 326 | 0.100 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2016 | 410 | 0.100 |
Why?
|
| Fractures, Bone | 2 | 2015 | 2045 | 0.100 |
Why?
|
| Geography | 4 | 2021 | 652 | 0.100 |
Why?
|
| Interleukin-6 | 5 | 2022 | 3210 | 0.100 |
Why?
|
| Environmental Monitoring | 1 | 2018 | 1460 | 0.100 |
Why?
|
| Premenopause | 1 | 2016 | 1038 | 0.100 |
Why?
|
| Pilot Projects | 2 | 2016 | 8639 | 0.100 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 1790 | 0.100 |
Why?
|
| Forced Expiratory Volume | 4 | 2017 | 1813 | 0.100 |
Why?
|
| Public Health | 2 | 2020 | 2671 | 0.100 |
Why?
|
| Vaccination | 1 | 2024 | 3368 | 0.090 |
Why?
|
| Health Status Indicators | 4 | 2018 | 970 | 0.090 |
Why?
|
| Immunity, Cellular | 1 | 2017 | 1553 | 0.090 |
Why?
|
| Caffeine | 1 | 2016 | 700 | 0.090 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2015 | 774 | 0.090 |
Why?
|
| Paraplegia | 2 | 2022 | 161 | 0.090 |
Why?
|
| Monte Carlo Method | 1 | 2016 | 1257 | 0.090 |
Why?
|
| Neovascularization, Physiologic | 2 | 2015 | 1347 | 0.090 |
Why?
|
| Alternative Splicing | 1 | 2016 | 1087 | 0.090 |
Why?
|
| Sensitivity and Specificity | 5 | 2019 | 14676 | 0.090 |
Why?
|
| Hyperkalemia | 1 | 2013 | 233 | 0.090 |
Why?
|
| Vasodilation | 1 | 2015 | 966 | 0.090 |
Why?
|
| Autophagy | 1 | 2019 | 1326 | 0.090 |
Why?
|
| Radiography | 7 | 2016 | 6975 | 0.090 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2017 | 518 | 0.090 |
Why?
|
| Docosahexaenoic Acids | 1 | 2017 | 906 | 0.090 |
Why?
|
| Pulmonary Veins | 1 | 2017 | 743 | 0.090 |
Why?
|
| Epidemiologic Methods | 2 | 2013 | 1336 | 0.090 |
Why?
|
| Weight Loss | 2 | 2020 | 2680 | 0.090 |
Why?
|
| Arteries | 1 | 2016 | 1121 | 0.090 |
Why?
|
| Benzimidazoles | 1 | 2016 | 858 | 0.090 |
Why?
|
| Wine | 2 | 2016 | 166 | 0.090 |
Why?
|
| Accidental Falls | 1 | 2018 | 1067 | 0.090 |
Why?
|
| Defibrillators, Implantable | 1 | 2020 | 1492 | 0.090 |
Why?
|
| Maternal Behavior | 1 | 2013 | 307 | 0.090 |
Why?
|
| Food Handling | 2 | 2024 | 154 | 0.090 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 4849 | 0.090 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2020 | 1228 | 0.090 |
Why?
|
| Proton Pump Inhibitors | 1 | 2015 | 534 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2019 | 2870 | 0.090 |
Why?
|
| Administration, Oral | 1 | 2018 | 4014 | 0.090 |
Why?
|
| Specimen Handling | 1 | 2014 | 701 | 0.090 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 1133 | 0.090 |
Why?
|
| Cadherins | 1 | 2014 | 902 | 0.090 |
Why?
|
| Greenhouse Effect | 1 | 2009 | 31 | 0.080 |
Why?
|
| Linseed Oil | 1 | 2009 | 5 | 0.080 |
Why?
|
| Sports | 1 | 2016 | 705 | 0.080 |
Why?
|
| Vital Capacity | 3 | 2017 | 970 | 0.080 |
Why?
|
| Societies, Medical | 3 | 2022 | 3923 | 0.080 |
Why?
|
| Calcium Signaling | 1 | 2014 | 732 | 0.080 |
Why?
|
| Flax | 1 | 2009 | 10 | 0.080 |
Why?
|
| Allergens | 1 | 2017 | 1433 | 0.080 |
Why?
|
| Tobacco Use Disorder | 1 | 2015 | 703 | 0.080 |
Why?
|
| New York | 1 | 2012 | 875 | 0.080 |
Why?
|
| Potassium Channels | 3 | 2017 | 537 | 0.080 |
Why?
|
| Child Welfare | 1 | 2013 | 521 | 0.080 |
Why?
|
| Ischemic Attack, Transient | 1 | 2015 | 874 | 0.080 |
Why?
|
| Venous Thrombosis | 1 | 2019 | 1304 | 0.080 |
Why?
|
| Potassium | 1 | 2013 | 1309 | 0.080 |
Why?
|
| Respiratory Tract Infections | 1 | 2017 | 1009 | 0.080 |
Why?
|
| Germany | 2 | 2024 | 872 | 0.080 |
Why?
|
| Osteogenesis | 1 | 2016 | 1272 | 0.080 |
Why?
|
| Sleep Deprivation | 1 | 2016 | 847 | 0.080 |
Why?
|
| Cluster Analysis | 2 | 2015 | 2706 | 0.080 |
Why?
|
| Environmental Pollutants | 1 | 2018 | 1276 | 0.080 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2015 | 820 | 0.080 |
Why?
|
| Vascular Diseases | 1 | 2017 | 1160 | 0.080 |
Why?
|
| Soybean Proteins | 1 | 2008 | 55 | 0.080 |
Why?
|
| Blood Platelets | 2 | 2016 | 2477 | 0.080 |
Why?
|
| ROC Curve | 1 | 2016 | 3582 | 0.080 |
Why?
|
| Self Report | 5 | 2019 | 3728 | 0.080 |
Why?
|
| Databases, Factual | 4 | 2023 | 7969 | 0.080 |
Why?
|
| Health Education | 1 | 2015 | 1049 | 0.080 |
Why?
|
| Membrane Glycoproteins | 2 | 2016 | 3696 | 0.080 |
Why?
|
| Adipocytes | 3 | 2024 | 1184 | 0.080 |
Why?
|
| Health Resources | 1 | 2015 | 934 | 0.080 |
Why?
|
| Isoflavones | 2 | 2008 | 136 | 0.080 |
Why?
|
| Genomics | 4 | 2020 | 5828 | 0.080 |
Why?
|
| Receptors, Leptin | 1 | 2009 | 350 | 0.080 |
Why?
|
| Insulin-Secreting Cells | 1 | 2015 | 897 | 0.080 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2014 | 1162 | 0.080 |
Why?
|
| Glucocorticoids | 1 | 2017 | 2160 | 0.070 |
Why?
|
| Choice Behavior | 1 | 2014 | 824 | 0.070 |
Why?
|
| Leisure Activities | 2 | 2022 | 308 | 0.070 |
Why?
|
| DNA Mutational Analysis | 1 | 2016 | 4109 | 0.070 |
Why?
|
| Osteoarthritis, Hip | 1 | 2012 | 409 | 0.070 |
Why?
|
| Resistin | 1 | 2008 | 172 | 0.070 |
Why?
|
| Growth Disorders | 1 | 2012 | 634 | 0.070 |
Why?
|
| Veterans | 1 | 2021 | 2652 | 0.070 |
Why?
|
| Erythrocytes | 1 | 2016 | 2413 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2022 | 4013 | 0.070 |
Why?
|
| Binding Sites | 4 | 2017 | 5993 | 0.070 |
Why?
|
| Sexual Behavior | 1 | 2017 | 2189 | 0.070 |
Why?
|
| Blood Proteins | 1 | 2012 | 1172 | 0.070 |
Why?
|
| Australia | 3 | 2016 | 1246 | 0.070 |
Why?
|
| Fibrinolysis | 1 | 2008 | 332 | 0.070 |
Why?
|
| Metabolomics | 1 | 2016 | 1658 | 0.070 |
Why?
|
| Hematopoiesis | 1 | 2016 | 2046 | 0.070 |
Why?
|
| Endothelial Cells | 2 | 2024 | 3550 | 0.070 |
Why?
|
| Comparative Effectiveness Research | 1 | 2012 | 709 | 0.070 |
Why?
|
| Nitric Oxide | 1 | 2016 | 2135 | 0.070 |
Why?
|
| Gender Identity | 1 | 2013 | 765 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 4340 | 0.070 |
Why?
|
| Liver Cirrhosis | 1 | 2017 | 1932 | 0.070 |
Why?
|
| Models, Theoretical | 2 | 2020 | 3568 | 0.070 |
Why?
|
| Treatment Outcome | 13 | 2022 | 64670 | 0.070 |
Why?
|
| Mass Screening | 2 | 2020 | 5425 | 0.070 |
Why?
|
| Weather | 2 | 2018 | 231 | 0.070 |
Why?
|
| Amino Acids | 1 | 2013 | 1703 | 0.070 |
Why?
|
| Linoleic Acid | 1 | 2007 | 158 | 0.070 |
Why?
|
| Social Class | 2 | 2016 | 1993 | 0.070 |
Why?
|
| Patient Compliance | 2 | 2015 | 2687 | 0.070 |
Why?
|
| Membrane Proteins | 3 | 2019 | 7844 | 0.070 |
Why?
|
| International Cooperation | 1 | 2013 | 1423 | 0.070 |
Why?
|
| Leukocytes | 1 | 2014 | 2024 | 0.070 |
Why?
|
| Potassium, Dietary | 2 | 2017 | 102 | 0.070 |
Why?
|
| Massachusetts | 3 | 2009 | 8836 | 0.070 |
Why?
|
| Heart Ventricles | 2 | 2015 | 3812 | 0.070 |
Why?
|
| Educational Status | 4 | 2019 | 2510 | 0.070 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 3899 | 0.070 |
Why?
|
| Placenta | 1 | 2015 | 1709 | 0.070 |
Why?
|
| Hospitals, Pediatric | 1 | 2015 | 1860 | 0.070 |
Why?
|
| Skin Aging | 1 | 2007 | 140 | 0.070 |
Why?
|
| Interpersonal Relations | 1 | 2013 | 1437 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2008 | 585 | 0.060 |
Why?
|
| Endovascular Procedures | 1 | 2020 | 2181 | 0.060 |
Why?
|
| Environmental Exposure | 2 | 2018 | 4479 | 0.060 |
Why?
|
| Osteoarthritis | 1 | 2014 | 1063 | 0.060 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2024 | 4575 | 0.060 |
Why?
|
| Antidepressive Agents | 2 | 2015 | 2893 | 0.060 |
Why?
|
| Proteins | 3 | 2017 | 5993 | 0.060 |
Why?
|
| Algorithms | 4 | 2019 | 14023 | 0.060 |
Why?
|
| Intra-Abdominal Fat | 2 | 2022 | 612 | 0.060 |
Why?
|
| Mitochondria | 1 | 2018 | 3620 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 1812 | 0.060 |
Why?
|
| Anorexia Nervosa | 1 | 2014 | 1361 | 0.060 |
Why?
|
| Repressor Proteins | 1 | 2016 | 2974 | 0.060 |
Why?
|
| Rural Population | 3 | 2014 | 2277 | 0.060 |
Why?
|
| Ultrasonography | 5 | 2016 | 5971 | 0.060 |
Why?
|
| Breast Neoplasms | 3 | 2019 | 20981 | 0.060 |
Why?
|
| Amyloid beta-Peptides | 1 | 2018 | 3840 | 0.060 |
Why?
|
| Fish Products | 1 | 2004 | 30 | 0.060 |
Why?
|
| Models, Statistical | 5 | 2019 | 5077 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2016 | 8303 | 0.060 |
Why?
|
| Ankle Brachial Index | 2 | 2017 | 163 | 0.060 |
Why?
|
| Intelligence Tests | 2 | 2017 | 503 | 0.060 |
Why?
|
| Internal-External Control | 2 | 2017 | 358 | 0.060 |
Why?
|
| Vehicle Emissions | 1 | 2009 | 655 | 0.060 |
Why?
|
| Food Analysis | 1 | 2005 | 103 | 0.060 |
Why?
|
| Food Hypersensitivity | 1 | 2012 | 726 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2016 | 3598 | 0.060 |
Why?
|
| Premature Birth | 1 | 2017 | 1781 | 0.060 |
Why?
|
| Parents | 2 | 2016 | 3564 | 0.060 |
Why?
|
| Pregnancy Trimesters | 2 | 2016 | 197 | 0.060 |
Why?
|
| Program Evaluation | 1 | 2013 | 2487 | 0.060 |
Why?
|
| Activities of Daily Living | 1 | 2014 | 2420 | 0.060 |
Why?
|
| Ascorbic Acid | 1 | 2007 | 654 | 0.060 |
Why?
|
| Receptors, Transferrin | 2 | 2020 | 291 | 0.060 |
Why?
|
| TRPM Cation Channels | 2 | 2017 | 139 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2270 | 0.060 |
Why?
|
| Time | 2 | 2017 | 545 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 4947 | 0.060 |
Why?
|
| DNA-Binding Proteins | 2 | 2018 | 9566 | 0.060 |
Why?
|
| Cell Movement | 1 | 2016 | 5195 | 0.060 |
Why?
|
| Platelet Count | 2 | 2016 | 782 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2019 | 4488 | 0.050 |
Why?
|
| Nucleic Acid Conformation | 2 | 2018 | 896 | 0.050 |
Why?
|
| Lung Neoplasms | 3 | 2017 | 13382 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2016 | 3450 | 0.050 |
Why?
|
| Catheter Ablation | 1 | 2017 | 2751 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2016 | 4933 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2012 | 6224 | 0.050 |
Why?
|
| Riboflavin | 1 | 2023 | 107 | 0.050 |
Why?
|
| Enteroendocrine Cells | 1 | 2024 | 78 | 0.050 |
Why?
|
| Circadian Rhythm | 1 | 2014 | 2570 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2019 | 20600 | 0.050 |
Why?
|
| Marital Status | 2 | 2017 | 425 | 0.050 |
Why?
|
| Hospital Mortality | 1 | 2017 | 5296 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2018 | 4795 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2016 | 9001 | 0.050 |
Why?
|
| Myocardial Ischemia | 1 | 2013 | 2133 | 0.050 |
Why?
|
| Multiple Sclerosis | 1 | 2017 | 3222 | 0.050 |
Why?
|
| Adipogenesis | 2 | 2015 | 365 | 0.050 |
Why?
|
| Fast Foods | 1 | 2024 | 210 | 0.050 |
Why?
|
| Iron, Dietary | 2 | 2016 | 148 | 0.050 |
Why?
|
| Chromatography, Liquid | 2 | 2016 | 982 | 0.050 |
Why?
|
| Altruism | 1 | 2023 | 208 | 0.050 |
Why?
|
| Statistics as Topic | 3 | 2016 | 2359 | 0.050 |
Why?
|
| Gene Expression | 3 | 2022 | 7567 | 0.050 |
Why?
|
| Hospitalization | 1 | 2021 | 10712 | 0.050 |
Why?
|
| Actinin | 1 | 2022 | 163 | 0.050 |
Why?
|
| Leptin | 1 | 2009 | 1595 | 0.050 |
Why?
|
| Muscle Proteins | 2 | 2017 | 1149 | 0.050 |
Why?
|
| Models, Economic | 1 | 2005 | 714 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2019 | 1074 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 2 | 2016 | 1602 | 0.050 |
Why?
|
| Metabolic Equivalent | 1 | 2020 | 15 | 0.050 |
Why?
|
| Syndrome | 2 | 2017 | 3269 | 0.050 |
Why?
|
| Pharmacoepidemiology | 2 | 2015 | 351 | 0.050 |
Why?
|
| Quadriplegia | 1 | 2022 | 226 | 0.050 |
Why?
|
| Stress, Mechanical | 2 | 2016 | 1674 | 0.050 |
Why?
|
| Aspirin | 1 | 2012 | 3128 | 0.050 |
Why?
|
| Ecuador | 1 | 2020 | 62 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2019 | 2915 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 5777 | 0.040 |
Why?
|
| Hospitals, Psychiatric | 1 | 2021 | 318 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2016 | 10421 | 0.040 |
Why?
|
| Singapore | 1 | 2020 | 292 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor B | 1 | 2019 | 25 | 0.040 |
Why?
|
| Health Policy | 1 | 2012 | 2680 | 0.040 |
Why?
|
| Ethanol | 2 | 2016 | 1322 | 0.040 |
Why?
|
| Transferrin | 1 | 2020 | 283 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2016 | 1186 | 0.040 |
Why?
|
| Body Fluid Compartments | 1 | 2019 | 50 | 0.040 |
Why?
|
| Receptors, Vasopressin | 1 | 2019 | 105 | 0.040 |
Why?
|
| Nursing Research | 1 | 2020 | 80 | 0.040 |
Why?
|
| Caspase 9 | 1 | 2019 | 184 | 0.040 |
Why?
|
| Heterozygote | 2 | 2016 | 2778 | 0.040 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2011 | 2020 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2004 | 1664 | 0.040 |
Why?
|
| Retrospective Studies | 7 | 2018 | 80673 | 0.040 |
Why?
|
| RNA Interference | 2 | 2018 | 2816 | 0.040 |
Why?
|
| Survivors | 1 | 2009 | 2369 | 0.040 |
Why?
|
| Cardiac-Gated Imaging Techniques | 1 | 2019 | 139 | 0.040 |
Why?
|
| World Health Organization | 2 | 2015 | 1321 | 0.040 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2018 | 55 | 0.040 |
Why?
|
| Causality | 2 | 2015 | 1243 | 0.040 |
Why?
|
| Troponin I | 1 | 2023 | 652 | 0.040 |
Why?
|
| Drosophila melanogaster | 2 | 2019 | 1711 | 0.040 |
Why?
|
| Advance Directives | 1 | 2020 | 249 | 0.040 |
Why?
|
| Cooperative Behavior | 2 | 2016 | 1505 | 0.040 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2018 | 149 | 0.040 |
Why?
|
| Selection, Genetic | 1 | 2023 | 871 | 0.040 |
Why?
|
| South Africa | 1 | 2024 | 1843 | 0.040 |
Why?
|
| Myosin-Light-Chain Phosphatase | 1 | 2017 | 20 | 0.040 |
Why?
|
| Lod Score | 1 | 2018 | 600 | 0.040 |
Why?
|
| Chromans | 1 | 2018 | 117 | 0.040 |
Why?
|
| Antiporters | 1 | 2019 | 276 | 0.040 |
Why?
|
| Hormones | 1 | 2022 | 869 | 0.040 |
Why?
|
| Forecasting | 1 | 2007 | 2928 | 0.040 |
Why?
|
| Fatigue | 2 | 2016 | 1550 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2013 | 4786 | 0.040 |
Why?
|
| Amino Acid Transport System y+L | 1 | 2017 | 17 | 0.040 |
Why?
|
| Amino Acid Transport System ASC | 1 | 2017 | 16 | 0.040 |
Why?
|
| Transfection | 2 | 2017 | 5750 | 0.040 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2018 | 224 | 0.040 |
Why?
|
| Drug Administration Routes | 1 | 2017 | 150 | 0.040 |
Why?
|
| Phosphoglycerate Dehydrogenase | 1 | 2017 | 37 | 0.040 |
Why?
|
| Complement Factor B | 1 | 2017 | 57 | 0.040 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2023 | 787 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2017 | 4250 | 0.040 |
Why?
|
| Muscles | 1 | 2022 | 1567 | 0.040 |
Why?
|
| RGS Proteins | 1 | 2017 | 74 | 0.040 |
Why?
|
| Tachycardia, Paroxysmal | 1 | 2017 | 30 | 0.040 |
Why?
|
| Sural Nerve | 1 | 2017 | 105 | 0.040 |
Why?
|
| France | 1 | 2018 | 492 | 0.040 |
Why?
|
| Smoking Cessation | 2 | 2019 | 2057 | 0.040 |
Why?
|
| Risk Management | 1 | 2020 | 557 | 0.040 |
Why?
|
| Normal Distribution | 1 | 2017 | 272 | 0.030 |
Why?
|
| Physical Chromosome Mapping | 1 | 2017 | 183 | 0.030 |
Why?
|
| Inheritance Patterns | 1 | 2019 | 341 | 0.030 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2017 | 82 | 0.030 |
Why?
|
| Diabetic Nephropathies | 1 | 2024 | 972 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 2 | 2009 | 344 | 0.030 |
Why?
|
| Cerebral Arteries | 1 | 2019 | 490 | 0.030 |
Why?
|
| Poultry | 1 | 2016 | 80 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2017 | 135 | 0.030 |
Why?
|
| Body Surface Area | 1 | 2017 | 197 | 0.030 |
Why?
|
| Iron Overload | 2 | 2008 | 239 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 4538 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2017 | 2401 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 2019 | 551 | 0.030 |
Why?
|
| Cohort Effect | 1 | 2016 | 39 | 0.030 |
Why?
|
| Gestational Age | 2 | 2016 | 3577 | 0.030 |
Why?
|
| Solanum tuberosum | 1 | 2016 | 46 | 0.030 |
Why?
|
| Beer | 1 | 2016 | 134 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2017 | 294 | 0.030 |
Why?
|
| Apolipoprotein E2 | 1 | 2016 | 135 | 0.030 |
Why?
|
| Body Temperature Regulation | 1 | 2018 | 292 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2022 | 1002 | 0.030 |
Why?
|
| Claudins | 1 | 2017 | 117 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2017 | 361 | 0.030 |
Why?
|
| Cells, Cultured | 3 | 2018 | 18926 | 0.030 |
Why?
|
| Apolipoprotein B-100 | 1 | 2016 | 157 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2018 | 462 | 0.030 |
Why?
|
| England | 1 | 2017 | 526 | 0.030 |
Why?
|
| Lipodystrophy | 1 | 2017 | 145 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 2017 | 658 | 0.030 |
Why?
|
| Infant Behavior | 1 | 2017 | 156 | 0.030 |
Why?
|
| Canada | 1 | 2021 | 2125 | 0.030 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2016 | 80 | 0.030 |
Why?
|
| Lumbar Vertebrae | 2 | 2017 | 1876 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2016 | 370 | 0.030 |
Why?
|
| Erythropoietin | 1 | 2020 | 719 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2014 | 1754 | 0.030 |
Why?
|
| Coffea | 1 | 2015 | 22 | 0.030 |
Why?
|
| Carbonated Beverages | 1 | 2017 | 210 | 0.030 |
Why?
|
| New Zealand | 1 | 2016 | 358 | 0.030 |
Why?
|
| Hippocampus | 2 | 2018 | 3757 | 0.030 |
Why?
|
| Death | 1 | 2020 | 675 | 0.030 |
Why?
|
| Colombia | 1 | 2016 | 282 | 0.030 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2015 | 32 | 0.030 |
Why?
|
| Libido | 1 | 2016 | 124 | 0.030 |
Why?
|
| Physicians | 1 | 2013 | 4583 | 0.030 |
Why?
|
| Edar Receptor | 1 | 2015 | 24 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2018 | 518 | 0.030 |
Why?
|
| Climate Change | 1 | 2022 | 498 | 0.030 |
Why?
|
| Oxidoreductases Acting on Sulfur Group Donors | 1 | 2015 | 32 | 0.030 |
Why?
|
| Altitude | 1 | 2016 | 163 | 0.030 |
Why?
|
| Mental Recall | 2 | 2015 | 1221 | 0.030 |
Why?
|
| Complement C3 | 1 | 2017 | 434 | 0.030 |
Why?
|
| Zebrafish | 2 | 2016 | 3001 | 0.030 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2015 | 72 | 0.030 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2016 | 225 | 0.030 |
Why?
|
| Cultured Milk Products | 1 | 2014 | 8 | 0.030 |
Why?
|
| Cholesterol, Dietary | 1 | 2015 | 224 | 0.030 |
Why?
|
| Hospitals, University | 1 | 2017 | 566 | 0.030 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 746 | 0.030 |
Why?
|
| Biological Availability | 1 | 2015 | 389 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 2018 | 633 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2022 | 1060 | 0.030 |
Why?
|
| Greece | 1 | 2015 | 340 | 0.030 |
Why?
|
| Nonverbal Communication | 1 | 2015 | 62 | 0.030 |
Why?
|
| Hydrodynamics | 1 | 2016 | 168 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2016 | 386 | 0.030 |
Why?
|
| C-Peptide | 1 | 2016 | 441 | 0.030 |
Why?
|
| Cyclins | 1 | 2017 | 594 | 0.030 |
Why?
|
| Second Messenger Systems | 1 | 2015 | 201 | 0.030 |
Why?
|
| INDEL Mutation | 1 | 2015 | 265 | 0.030 |
Why?
|
| Endocrine System | 1 | 2015 | 114 | 0.030 |
Why?
|
| Kallikreins | 1 | 2016 | 220 | 0.030 |
Why?
|
| Turkey | 1 | 2015 | 254 | 0.030 |
Why?
|
| Antigens, Nuclear | 1 | 2015 | 184 | 0.030 |
Why?
|
| Basilar Artery | 1 | 2015 | 205 | 0.030 |
Why?
|
| Africa | 1 | 2016 | 714 | 0.030 |
Why?
|
| Vulnerable Populations | 1 | 2020 | 705 | 0.030 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2015 | 103 | 0.030 |
Why?
|
| Child Nutrition Disorders | 1 | 2016 | 139 | 0.030 |
Why?
|
| Molecular Epidemiology | 1 | 2016 | 470 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2020 | 1525 | 0.030 |
Why?
|
| Cation Transport Proteins | 1 | 2017 | 326 | 0.030 |
Why?
|
| Paternal Exposure | 1 | 2015 | 96 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2016 | 470 | 0.030 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2017 | 476 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2014 | 4111 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2015 | 652 | 0.030 |
Why?
|
| Computer Simulation | 2 | 2019 | 6225 | 0.030 |
Why?
|
| Blood | 1 | 2016 | 596 | 0.030 |
Why?
|
| Vitamin B 6 | 1 | 2015 | 234 | 0.030 |
Why?
|
| Hyperphagia | 1 | 2014 | 139 | 0.030 |
Why?
|
| Cyclic GMP | 1 | 2015 | 395 | 0.030 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2015 | 152 | 0.030 |
Why?
|
| Neoplasm Proteins | 2 | 2017 | 3594 | 0.030 |
Why?
|
| Social Support | 1 | 2024 | 2175 | 0.030 |
Why?
|
| Subtilisins | 1 | 2014 | 79 | 0.030 |
Why?
|
| Reference Standards | 1 | 2017 | 1005 | 0.030 |
Why?
|
| Genetic Code | 1 | 2014 | 138 | 0.030 |
Why?
|
| Skin | 1 | 2007 | 4473 | 0.030 |
Why?
|
| Phosphorus, Dietary | 1 | 2013 | 20 | 0.030 |
Why?
|
| Quality Control | 1 | 2016 | 834 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2016 | 3367 | 0.030 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2014 | 127 | 0.030 |
Why?
|
| Copper | 1 | 2016 | 365 | 0.030 |
Why?
|
| Genetics, Population | 1 | 2018 | 935 | 0.030 |
Why?
|
| Cough | 1 | 2017 | 594 | 0.030 |
Why?
|
| Restless Legs Syndrome | 1 | 2016 | 233 | 0.030 |
Why?
|
| Nuts | 1 | 2015 | 264 | 0.030 |
Why?
|
| Single Parent | 1 | 2013 | 32 | 0.030 |
Why?
|
| Dizziness | 1 | 2016 | 258 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 10755 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2016 | 942 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2019 | 1443 | 0.030 |
Why?
|
| Rupture, Spontaneous | 1 | 2014 | 362 | 0.030 |
Why?
|
| Pulsatile Flow | 1 | 2014 | 320 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2015 | 6011 | 0.030 |
Why?
|
| Nausea | 1 | 2016 | 679 | 0.030 |
Why?
|
| Intracranial Hemorrhages | 1 | 2018 | 809 | 0.030 |
Why?
|
| Anisotropy | 1 | 2016 | 1284 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 931 | 0.030 |
Why?
|
| Genetic Research | 1 | 2013 | 172 | 0.030 |
Why?
|
| Necrosis | 1 | 2017 | 1611 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2016 | 22129 | 0.030 |
Why?
|
| North America | 1 | 2016 | 1281 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2016 | 23415 | 0.030 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2015 | 420 | 0.030 |
Why?
|
| Lipoproteins, LDL | 1 | 2016 | 643 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 2452 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 9416 | 0.030 |
Why?
|
| European Union | 1 | 2013 | 157 | 0.030 |
Why?
|
| Peripheral Arterial Disease | 1 | 2024 | 1274 | 0.030 |
Why?
|
| Endonucleases | 1 | 2015 | 370 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2017 | 1867 | 0.030 |
Why?
|
| Sexual Partners | 1 | 2017 | 800 | 0.030 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2017 | 389 | 0.030 |
Why?
|
| Chromatin | 1 | 2024 | 2945 | 0.020 |
Why?
|
| Independent Living | 1 | 2016 | 579 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2017 | 1734 | 0.020 |
Why?
|
| Megakaryocytes | 1 | 2016 | 566 | 0.020 |
Why?
|
| Child Day Care Centers | 1 | 2013 | 122 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2015 | 1150 | 0.020 |
Why?
|
| Advisory Committees | 1 | 2016 | 788 | 0.020 |
Why?
|
| Zinc | 1 | 2016 | 672 | 0.020 |
Why?
|
| Video Games | 1 | 2014 | 197 | 0.020 |
Why?
|
| Milk | 1 | 2014 | 440 | 0.020 |
Why?
|
| Workflow | 1 | 2016 | 850 | 0.020 |
Why?
|
| Television | 1 | 2014 | 407 | 0.020 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2014 | 582 | 0.020 |
Why?
|
| Flavonoids | 1 | 2014 | 444 | 0.020 |
Why?
|
| Diuretics | 1 | 2014 | 611 | 0.020 |
Why?
|
| Hand Strength | 1 | 2014 | 456 | 0.020 |
Why?
|
| Muscle Weakness | 1 | 2014 | 412 | 0.020 |
Why?
|
| Parent-Child Relations | 1 | 2016 | 762 | 0.020 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2015 | 376 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2016 | 1685 | 0.020 |
Why?
|
| Retinal Diseases | 1 | 2017 | 705 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2015 | 989 | 0.020 |
Why?
|
| Body Height | 1 | 2017 | 1565 | 0.020 |
Why?
|
| Homozygote | 1 | 2015 | 1775 | 0.020 |
Why?
|
| Serine Endopeptidases | 1 | 2016 | 1022 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2016 | 14393 | 0.020 |
Why?
|
| Cleft Lip | 1 | 2016 | 506 | 0.020 |
Why?
|
| Pedigree | 1 | 2018 | 4537 | 0.020 |
Why?
|
| DNA Primers | 1 | 2014 | 2815 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 1720 | 0.020 |
Why?
|
| Cleft Palate | 1 | 2016 | 589 | 0.020 |
Why?
|
| Actins | 1 | 2017 | 2046 | 0.020 |
Why?
|
| Steroids | 1 | 2015 | 929 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2016 | 1334 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2017 | 1741 | 0.020 |
Why?
|
| Drosophila | 1 | 2017 | 1495 | 0.020 |
Why?
|
| Mutation | 1 | 2015 | 30006 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 3419 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2017 | 2696 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2016 | 1603 | 0.020 |
Why?
|
| Action Potentials | 1 | 2017 | 1834 | 0.020 |
Why?
|
| London | 1 | 2009 | 233 | 0.020 |
Why?
|
| Japan | 1 | 2014 | 1373 | 0.020 |
Why?
|
| Brazil | 1 | 2013 | 1229 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2012 | 674 | 0.020 |
Why?
|
| Ribosomes | 1 | 2012 | 494 | 0.020 |
Why?
|
| DNA Replication | 1 | 2016 | 1415 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2019 | 2802 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2019 | 3430 | 0.020 |
Why?
|
| Seeds | 1 | 2009 | 122 | 0.020 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2016 | 955 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2016 | 1873 | 0.020 |
Why?
|
| Nurses | 1 | 2018 | 2476 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 2892 | 0.020 |
Why?
|
| Drug Monitoring | 1 | 2014 | 961 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2019 | 3114 | 0.020 |
Why?
|
| Solubility | 1 | 2009 | 1085 | 0.020 |
Why?
|
| Gout | 1 | 2015 | 621 | 0.020 |
Why?
|
| Motor Vehicles | 1 | 2009 | 282 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2018 | 2635 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2014 | 1496 | 0.020 |
Why?
|
| Albumins | 1 | 2010 | 575 | 0.020 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2008 | 278 | 0.020 |
Why?
|
| Patient Selection | 1 | 2019 | 4245 | 0.020 |
Why?
|
| Schools | 1 | 2016 | 1483 | 0.020 |
Why?
|
| Mice | 4 | 2016 | 81324 | 0.020 |
Why?
|
| Affect | 1 | 2015 | 1486 | 0.020 |
Why?
|
| Maternal Health Services | 1 | 2012 | 460 | 0.020 |
Why?
|
| Thorax | 1 | 2010 | 555 | 0.020 |
Why?
|
| Propensity Score | 1 | 2014 | 1913 | 0.020 |
Why?
|
| Behavior | 1 | 2009 | 540 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2017 | 3016 | 0.020 |
Why?
|
| Knee Joint | 1 | 2015 | 1677 | 0.020 |
Why?
|
| Acute Coronary Syndrome | 1 | 2019 | 2191 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2022 | 8000 | 0.020 |
Why?
|
| Rural Health | 1 | 2007 | 296 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2008 | 998 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 1744 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2018 | 3536 | 0.020 |
Why?
|
| Synapses | 1 | 2015 | 1755 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2014 | 2024 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 2091 | 0.020 |
Why?
|
| Family | 1 | 2016 | 3193 | 0.020 |
Why?
|
| Leg | 1 | 2010 | 1087 | 0.020 |
Why?
|
| Consensus | 1 | 2014 | 3133 | 0.020 |
Why?
|
| Thrombosis | 1 | 2019 | 2944 | 0.020 |
Why?
|
| RNA | 1 | 2014 | 2708 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 2413 | 0.010 |
Why?
|
| Hypertriglyceridemia | 1 | 2007 | 293 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 2007 | 991 | 0.010 |
Why?
|
| Abdomen | 1 | 2010 | 1128 | 0.010 |
Why?
|
| Interview, Psychological | 1 | 2007 | 809 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2016 | 3388 | 0.010 |
Why?
|
| Base Sequence | 1 | 2014 | 12404 | 0.010 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2015 | 2787 | 0.010 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2016 | 1874 | 0.010 |
Why?
|
| Particulate Matter | 1 | 2014 | 2597 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2015 | 7043 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2021 | 6818 | 0.010 |
Why?
|
| Bipolar Disorder | 1 | 2018 | 5091 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2015 | 5520 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2008 | 1834 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 7574 | 0.010 |
Why?
|
| Air Pollutants | 1 | 2014 | 2889 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 16947 | 0.010 |
Why?
|
| Schizophrenia | 1 | 2018 | 6929 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 12975 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2010 | 6817 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 8529 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2010 | 3086 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2020 | 15634 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 11103 | 0.010 |
Why?
|